Cargando…
Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
BACKGROUND: Nicorandil was reported to improve microvascular dysfunction and reduce reperfusion injury when administered before primary percutaneous coronary intervention. In this multicenter, prospective, randomized, double‐blind clinical trial (CHANGE [Effects of Nicorandil Administration on Infar...
Autores principales: | Qian, Geng, Zhang, Ying, Dong, Wei, Jiang, Zi‐Chao, Li, Tao, Cheng, Liu‐Quan, Zou, Yu‐Ting, Jiang, Xiao‐Si, Zhou, Hao, A, Xin, Li, Ping, Chen, Mu‐Lei, Su, Xi, Tian, Jin‐Wen, Shi, Bei, Li, Zong‐Zhuang, Wu, Yan‐Qing, Li, Yong‐Jun, Chen, Yun‐Dai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683654/ https://www.ncbi.nlm.nih.gov/pubmed/36073634 http://dx.doi.org/10.1161/JAHA.122.026232 |
Ejemplares similares
-
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
por: JIANG, Xiao-Si, et al.
Publicado: (2020) -
Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Wang, Shanjie, et al.
Publicado: (2019) -
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017) -
Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018) -
Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
por: Geng, Ning, et al.
Publicado: (2021)